Before you sell to, join or invest in Acurx Pharmaceuticals, Inc.
MentionFox check on Acurx Pharmaceuticals, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/acurx-pharmaceuticals-inc-form-d-25000002
Check Acurx Pharmaceuticals, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Acurx Pharmaceuticals, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Acurx Pharmaceuticals, Inc. filed a Form D with the Securities and Exchange Commission on 2025-05-20.
Acurx Pharmaceuticals, Inc. filed a Form D notice of an exempt securities offering with the SEC on May 20, 2025. Its industry group is Pharmaceuticals. It names David Luci (Executive Officer), Robert DeLuccia (Executive Officer, Director), Robert Shawah (Executive Officer) (SEC Form D, May 20, 2025).
Is this your company?
Sell to companies like Acurx Pharmaceuticals, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-20 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Acurx Pharmaceuticals, Inc.
Free to see. No signup.
More on the people and the money behind Acurx Pharmaceuticals, Inc., from the filings we hold.
Pharmaceuticals raises by companies based in New York, filed within 90 days of this one, largest first.
Get an email when Acurx Pharmaceuticals, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Acurx Pharmaceuticals, Inc. raises, hires or launches. No email unless you switch it on.
Watch Acurx Pharmaceuticals, Inc. →Get the full cited report on Acurx Pharmaceuticals, Inc.
What the filing shows about Acurx Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Acurx Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Acurx Pharmaceuticals, Inc.'s address as 259 Liberty Avenue, Staten Island, NY 10305.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Acurx Pharmaceuticals, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Acurx Pharmaceuticals, Inc. See pricing
Acurx Pharmaceuticals, Inc. is a registered filer with the SEC (CIK 1736243) and has filed since 2025-01-17. 5 filings are on record, the latest on 2026-04-29.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Acurx Pharmaceuticals, Inc.'s Form D of 2025-05-20 names David Luci, Robert DeLuccia, Robert Shawah and 5 more as its officers, directors or promoters.
Its new offerings report $14.35M sold across 4 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
David Luci is named as Executive Officer on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 20 May 2025, one of 8 people that filing names.
Robert DeLuccia is named as Executive Officer and Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 20 May 2025, one of 8 people that filing names.
Robert Shawah is named as Executive Officer on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 20 May 2025, one of 8 people that filing names.
Jack Dean is named as Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 20 May 2025, one of 8 people that filing names.
James Donohue is named as Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 20 May 2025, one of 8 people that filing names.
Thomas Harrison is named as Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 20 May 2025, one of 8 people that filing names.
Carl Sailer is named as Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 20 May 2025, one of 8 people that filing names.
Joseph Scodari is named as Director on the Form D that Acurx Pharmaceuticals, Inc. filed with the SEC on 20 May 2025, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2025-05-20 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Acurx Pharmaceuticals, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Acurx Pharmaceuticals, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Acurx Pharmaceuticals, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Acurx Pharmaceuticals, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Acurx Pharmaceuticals, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-02 (ir.acurxpharma.com).
Each opens in a new tab, filled in for Acurx Pharmaceuticals, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in New York
https://mentionfox.com/funding/acurx-pharmaceuticals-inc-form-d-25000002